scholarly journals Probiotics and Isoflavones as a Promising Therapeutic for Calcium Status and Bone Health: A Narrative Review

Foods ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 2685
Author(s):  
Iskandar Azmy Harahap ◽  
Joanna Suliburska
Keyword(s):  
Bone Formation ◽  
Bone Health ◽  
Metabolic Pathways ◽  
Calcium Uptake ◽  
Research Area ◽  
Clinical Effects ◽  
Significant Extent ◽  
Postmenopausal Symptoms ◽  
Osteoblast Activity ◽  
Calcium Status

Probiotics have potential clinical effects for treating and preventing osteoporosis. Meanwhile, isoflavones have attracted much attention due to their ability to prevent postmenopausal symptoms. Research has established that probiotics and isoflavones can regulate hormones, immune cells, and the gastrointestinal system, acting as links in the gut–bone axis. However, combining the effects of probiotics and isoflavones on calcium status and bone health is a more novel and a still-evolving research area. Lactobacillus and Bifidobacterium are the foremost strains that influence bone health to a significant extent. Among the isoflavones, daidzein, genistein, and the metabolites of genistein (such as equol) stimulate bone formation. It can be concluded that probiotics and isoflavones promote bone health by regulating calcium uptake, gut microbiota, and various metabolic pathways that are associated with osteoblast activity and bone formation. Nevertheless, further experiments of probiotics and isoflavones are still necessary to confirm the association between calcium bioavailability and bone health.

Titanium Acts on Osteoblast Translational Process

2008 ◽  
Vol 34 (4) ◽  
pp. 190-194 ◽  
Author(s):  
Annalisa Palmieri ◽  
Furio Pezzetti ◽  
Anna Avantaggiato ◽  
Lorenzo Lo Muzio ◽  
Antonio Scarano ◽  
...  
Keyword(s):  
Bone Formation ◽  
Translation Regulation ◽  
Mirna Sequence ◽  
Clinical Effects ◽  
Mirna Microarray ◽  
Osteoblast Activity ◽  
Genome Wide ◽  
Novel Method ◽  
Translational Process

Abstract Titanium is a highly biocompatible material and very osteogenic in vivo. However, how titanium regulates osteoblast activity to promote bone formation is incompletely characterized. We, therefore, attempted to get more information by using microRNA (miRNA) microarray techniques to investigate translation regulation in osteoblasts grown on titanium disks. The miRNA oligonucleotide microarray provides a novel method to carry out genome-wide miRNA profiling in human samples. By using miRNA microarrays containing 329 probes designed from the human miRNA sequence, several miRNA were identified in osteoblast-like cell line (MG 63) grown on titanium disks. There were 13 up-regulated miRNAs (ie, mir-23a, mir-222, mir-523, mir-22, mir-23b, mir-143, mir-377, mir-24, mir-422b, mir-26a, mir-29a, mir-17–5p, mir-182) and 2 down-regulated miRNAs (ie, mir-187, mir-339). The data reported are, to our knowledge, the first study on translation regulation in osteoblasts exposed to titanium. The data can be relevant to understand better the molecular mechanism of osteoblast activation and as a model for comparing other materials with similar clinical effects.

scholarly journals Bone health in spacefaring rodents and primates: systematic review and meta-analysis

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Jingyan Fu ◽  
Matthew Goldsmith ◽  
Sequoia D. Crooks ◽  
Sean F. Condon ◽  
Martin Morris ◽  
...  
Keyword(s):  
Bone Formation ◽  
Trabecular Bone ◽  
Bone Health ◽  
Volume Fraction ◽  
Meta Analysis ◽  
Bone Volume ◽  
Trabecular Bone Volume ◽  
Bone Volume Fraction ◽  
Percentage Difference ◽  
Induced Changes

AbstractAnimals in space exploration studies serve both as a model for human physiology and as a means to understand the physiological effects of microgravity. To quantify the microgravity-induced changes to bone health in animals, we systematically searched Medline, Embase, Web of Science, BIOSIS, and NASA Technical reports. We selected 40 papers focusing on the bone health of 95 rats, 61 mice, and 9 rhesus monkeys from 22 space missions. The percentage difference from ground control in rodents was –24.1% [Confidence interval: −43.4, −4.9] for trabecular bone volume fraction and –5.9% [−8.0, −3.8] for the cortical area. In primates, trabecular bone volume fraction was lower by –25.2% [−35.6, −14.7] in spaceflight animals compared to GC. Bone formation indices in rodent trabecular and cortical bone were significantly lower in microgravity. In contrast, osteoclast numbers were not affected in rats and were variably affected in mice. Thus, microgravity induces bone deficits in rodents and primates likely through the suppression of bone formation.

Regulation of bone repletion in rats subjected to varying low-calcium stress

1984 ◽  
Vol 246 (2) ◽  
pp. R190-R196 ◽  
Author(s):  
R. H. Drivdahl ◽  
C. C. Liu ◽  
D. J. Baylink
Keyword(s):  
Bone Formation ◽  
Formation Rate ◽  
Bone Volume ◽  
Strong Positive Correlation ◽  
Sprague Dawley ◽  
Bone Formation Rate ◽  
Osteoblast Activity ◽  
Calcium Stress ◽  
Sprague Dawley Rats ◽  
Very High

Weanling Sprague-Dawley rats subjected to varying degrees of low-Ca dietary stress (depletion) showed graded increases in the rate of endosteal bone formation when normal dietary Ca was restored (repletion). There was a strong positive correlation between the rate of bone resorption in depletion and the rate of bone formation attained after 1 wk of repletion. However, bone formation declined rapidly within the first 4 wk of repletion, despite the persistence of a substantial endosteal bone volume deficit. Furthermore the medullary area (indicative of bone volume) did not by itself determine the bone formation rate. Bone volume in test groups was restored to control levels after 6 mo of repletion, and this result could be predicted by a kinetic analysis. Thus, although very high rates of formation in early repletion decline rapidly, smaller increments relative to controls must be sustained for long periods. Our data indicate that increased formation rats at all stages of repletion are a consequence of elevations in both osteoblast number and osteoblast activity.

scholarly journals Farmakokinetika dan Bioavailability Senyawa Golongan Santon Revew Komprehensif

2019 ◽  
Vol 8 (2) ◽  
pp. 46-51
Author(s):  
Meri Susanti
Keyword(s):  
Active Compound ◽  
Metabolic Pathways ◽  
Herbal Medicines ◽  
Bioactive Compound ◽  
Pharmacokinetic Profile ◽  
Evidence Based ◽  
Clinical Effects ◽  
Dosage Regimens ◽  
Link Data ◽  
Detailed Picture

The use of herbs for treating various ailment dates back several centuries. Evidence-based verification of the efficacy of Herbal medicines is still frequently lacking. Of particular interest is the question of bioavailability to assess to what degree and how fast compounds are absorbed after administration of herbal. Of further interest is the elucidation of metabolic pathways, and the assessment of elimination routes and their kinetics. These data become an important issue to link data from pharmacological assays and clinical effects. A better understanding of the pharmacokinetics and bioavailability of phytopharmaceuticals can also help in designing rational dosage regimens. To provide provide a detailed picture on ADME parameters (absorption, distribution, metabolism, and excretion) of some xanthone active compound, this article reviews the pharmacokinetic profile of 7 xanthones bioactive compound from the year 2009 onward.  

IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice

2001 ◽  
Vol 281 (2) ◽  
pp. E283-E288 ◽  
Author(s):  
Dennis L. Andress
Keyword(s):  
Bone Formation ◽  
Binding Protein ◽  
Formation Rate ◽  
Bone Matrix ◽  
Secretory Protein ◽  
Mineral Density ◽  
Bone Formation Rate ◽  
Ovariectomized Mice ◽  
Osteoblast Activity

Insulin-like growth factor binding protein-5 (IGFBP-5) is an osteoblast secretory protein that becomes incorporated into the mineralized bone matrix. In osteoblast cultures, IGFBP-5 stimulates cell proliferation by an IGF-independent mechanism. To evaluate whether IGFBP-5 can stimulate osteoblast activity and enhance bone accretion in a mouse model of osteoblast insufficiency, daily subcutaneous injections of either intact [IGFBP-5 (intact)] or carboxy-truncated IGFBP-5 [IGFBP-5-(1–169)] were given to ovariectomized (OVX) mice for 8 wk. Femur and spine bone mineral density (BMD), measured every 2 wk, showed early and sustained increases in response to IGFBP-5. Bone histomorphometry of cancellous bone showed significant elevations in the bone formation rate in both the femur metaphysis [IGFBP-5- (1)] only) and spine compared with OVX controls. IGFBP-5 also stimulated osteoblast number in the femur IGFBP-5-(1–169) only) and spine. These data indicate that IGFBP-5 effectively enhances bone formation and bone accretion in OVX mice by stimulating osteoblast activity. The finding that IGFBP-5-(1–169) is bioactive in vivo indicates that the carboxy-terminal portion is not required for this bone anabolic effect.

Strontium-Borosilicate-Co-Effects to Stimulate Bone Regeneration

2011 ◽  
Vol 685 ◽  
pp. 371-378
Author(s):  
Yu Hui Shen ◽  
Kui Bo Zhang ◽  
Hao Bo Pan ◽  
William W. Lu ◽  
Zhao Min Zheng ◽  
...  
Keyword(s):  
Bone Formation ◽  
Bone Regeneration ◽  
Dissolution Rate ◽  
Bone Health ◽  
Bone Growth ◽  
Special Role ◽  
Psychomotor Skills ◽  
Rapid Degradation ◽  
Naturally Occurring ◽  
High Dissolution Rate

As a naturally-occurring trace element, boron involves many life processes including embryogenesis, bone growth and maintenance, immune function and psychomotor skills. Thus, the low chemical durable glass based on 3-fold coordination boron network former shows potential in delivering boron for bone health. However, its high dissolution rate may result in cytotoxicity. The addition of strontium seems to be an effective approach not only inhibits its rapid degradation, but delivers strontium as a ‘drug’ to enhance the ability of bone formation. Thus, strontium-incorporated borosilicate shows special role in bone regeneration, in particular in women past menopause.

Edge AI Driven Technology Advancements Paving Way Towards New Capabilities

2020 ◽  
pp. 2040005
Author(s):  
Girish Kumar Agarwal ◽  
Mats Magnusson ◽  
Anders Johanson
Keyword(s):  
New Technology ◽  
Analytical Framework ◽  
Research Area ◽  
Dynamic Capability ◽  
Significant Extent ◽  
Manufacturing Firm ◽  
Resource Based View ◽  
Industrial Manufacturing ◽  
Stakeholder Groups ◽  
Start Ups

As industries hold the opportunity to embrace artificial intelligence (AI) driven innovation, their success to a significant extent will depend on the value the new technology generates for different business stakeholder groups. This is in turn dependent upon how management can embrace these techniques and change as companies will frequently need to transform both internal processes and offerings to customers in order to reap the benefits of AI. AI is a growing research area currently concentrated around technology and modeling of techniques and yet only few examples and limited research are available, on how AI technology enables new capabilities that can impact the value delivered as well as radically transform it. We thus need to understand what new capabilities these technologies bring about and how they are used. Based on three concrete empirical quasi-experiments, interviews conducted with start-ups and a Swedish industrial manufacturing firm dealing with outdoor power products (like grass-cutters, chain-saws, concrete-saws, etc.) for professional and consumer use and using an analytical framework derived from the Resource Based View, this paper explores capabilities enabled through Edge AI and the competitive advantage these may offer. Specific capabilities (self-calibration, enhanced-sensing, selective-capture and reputation) are identified and implications for theory are discussed, pointing out the importance to consider this type of technology not only as a resource, but rather as a dynamic capability in itself.

scholarly journals Novel Metabolic Pathways Associated with Serum Bone Turnover Markers in Healthy Young Adults

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 71-71
Author(s):  
Joseph Roberts ◽  
Moriah Bellissimo ◽  
Kaitlin Taibl ◽  
Karan Uppal ◽  
Dean Jones ◽  
...  
Keyword(s):  
Young Adults ◽  
Fatty Acid ◽  
Amino Acid ◽  
High Resolution ◽  
Bone Resorption ◽  
Bone Formation ◽  
Bone Turnover ◽  
Metabolic Pathways ◽  
Type I ◽  
Turnover Markers

Abstract Objectives Optimal bone health is maintained through a remodeling cycle consisting of resorption followed by formation. Procollagen type I N-terminal propeptide (P1NP) and C-terminal telopeptides of type I collagen (CTX) are biomarkers of bone metabolism that capture changes in bone formation and bone resorption, respectively. This study aimed to identify unique metabolic pathways related to bone turnover markers (BTMs) in healthy young adults. Methods This cross-sectional study included 34 healthy, young adults (19 females, average age 27.8 years). Bone mineral density (BMD) was assessed by dual-energy x-ray absorptiometry. Fasting plasma was analyzed using dual column liquid chromatography and ultra-high-resolution mass spectrometry for metabolomics. Serum levels of P1NP and CTX were measured with ELISA. Linear regression and pathway enrichment analyses were used to identify metabolic pathways related to the BTMs. Results All participants had a normal whole-body BMD T-score. Metabolites significantly associated with P1NP (at P < 0.05) were significantly enriched in pathways linked to the TCA cycle, pyruvate metabolism, and metabolism of B-vitamins important for energy production (e.g., niacin, thiamin). Other nutrition-related metabolic pathways associated with P1NP were amino acid (proline, arginine, glutamate) and vitamin C metabolism, which are important for collagen formation. Metabolites were associated with CTX levels (at P < 0.05), which were enriched within lipid and fatty acid beta-oxidation metabolic pathways, as well as fat soluble micronutrients pathways including, vitamin D metabolism, vitamin E metabolism, and bile acid biosynthesis. Conclusions High-resolution metabolomics identified several distinct plasma metabolic pathways, including energy-yielding metabolic pathways and pathways related to fatty acid, amino acid, and micronutrient metabolism that were associated with markers of bone formation and bone resorption. Characterizing these metabolism-related pathways associated with BTMs in healthy adults is an important step towards understanding the metabolic perturbations that lead to low bone mass in older and clinical populations. Funding Sources National Institutes of Health and Emory University.

The effect of tai chi chuan on bone remodeling and cytokines among breast cancer survivors: A feasibility trial

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 9610-9610
Author(s):  
L. J. Peppone ◽  
K. Mustian ◽  
R. N. Rosier ◽  
K. M. Piazza ◽  
D. G. Hicks ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Resorption ◽  
Bone Formation ◽  
Bone Remodeling ◽  
Bone Health ◽  
Tai Chi ◽  
Cell Function ◽  
Bone Cell ◽  
Post Intervention ◽  
Tai Chi Chuan

9610 Background: Weight-bearing exercise may slow the rate of bone loss associated with breast cancer treatment. The purpose of this study is to determine the effect of tai chi chuan (TCC) on bone health, as measured by the changes in the levels of bone resorption and bone formation. This study also aimed to investigate whether changes in bone health were correlated with growth and inflammation markers that serve as regulators of bone cell function. Methods: Female patients (N=16) who completed treatment for breast cancer within the past 30 months were randomly assigned to either the TCC group or the psycho-educational support group without exercise (ST) for 60 minutes, three times a week for a period of 12 weeks. Serum levels of bone resorption (N-telopeptides of type I collagen; NTx) and bone formation (bone specific alkaline phosphatase; BAP) were determined by ELISA at baseline and post-intervention. Using validated methods, a bone remodeling index (BRI) was calculated from levels of NTx and BAP. In addition, pre- and post-intervention levels of insulin-like growth factor binding protein 1 (IGFBP-1) and interleukin-2 (IL-2), markers associated with excessive bone resorption, were measured. Lastly, levels of interleukin-6 (IL-6), believed to enhance bone formation, were measured at both pre- and post-intervention. Results: ANCOVA analyses demonstrated that survivors in the TCC group experienced a greater increase in bone remodeling than those in the ST group (Δ BRITCC=1.6 vs Δ BRIST=0.2; p=0.04). All correlations were determined by Pearson's correlation coefficients. IGFBP-1 was negatively correlated with increasing bone remodeling levels (r=-0.43, p=0.14). IL-2 was also negatively correlated with increasing bone remodeling levels (r=-0.35, p=0.24). IL-6 was positively correlated with increasing bone remodeling levels (r=0.69, p=0.01). Conclusions: This pilot study suggests that TCC has positive effects on bone remodeling through changes in growth and inflammation factors that regulate bone cell function. A larger, more definitive trial examining the influence of TCC on bone remodeling is warranted. Funding: Sally Schindel Cone and R25 CA102618 No significant financial relationships to disclose.

scholarly journals Tamoxifen Stimulates Cancellous Bone Formation in Long Bones of Female Mice

Endocrinology ◽  
2005 ◽  
Vol 146 (3) ◽  
pp. 1060-1065 ◽  
Author(s):  
M. J. Perry ◽  
S. Gujra ◽  
T. Whitworth ◽  
J. H. Tobias
Keyword(s):  
Bone Formation ◽  
Protective Effect ◽  
Cancellous Bone ◽  
Bone Growth ◽  
Similar Response ◽  
Stimulatory Action ◽  
Female Mice ◽  
Estrogen Receptor Modulators ◽  
Osteoblast Activity ◽  
17Β Estradiol

Selective estrogen receptor modulators (SERMs) have been developed as a means of targeting estrogen’s protective effect on the skeleton in the treatment of postmenopausal osteoporosis. Although it is well established that SERMs such as tamoxifen inhibit bone resorption in a similar manner to estrogen, whether this agent shares estrogen’s stimulatory action on bone formation is currently unclear. To address this question, we compared the effect of treatment for 28 d with 17β-estradiol (E2; 0.1, 1.0 mg/kg·d) and tamoxifen (0.1, 1.0, or 10 mg/kg·d) on cancellous bone formation at the proximal tibial metaphysis of intact female mice. E2 stimulated the formation of new cancellous bone throughout the metaphysis. A similar response was observed after administration of tamoxifen, the magnitude of which was approximately 50% of that seen after E2. As expected, E2 was found to suppress longitudinal bone growth, but in contrast, this parameter was stimulated by tamoxifen. We conclude that tamoxifen acts as an agonist with respect to estrogen’s stimulatory action on bone formation but as an antagonist in terms of estrogen’s inhibition of longitudinal growth, suggesting that the protective effect of SERMs on the skeleton is partly mediated by stimulation of osteoblast activity.

Sign in / Sign up

Export Citation Format

Share Document